Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 002078.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Bad
0%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 15.51 0.88 0.76
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 33.76 11.94 8.92
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 3.79 9.72 9.36
Cash -3.08 0.87 0.90
Capex -24.00 -0.31 -0.25
Free Cash Flow 2.31 -0.10 0.10
Revenue -1.51 3.64 3.70
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 10.09 0.18 0.16
Operating Margin 9.68 0.12 0.11
ROA -0.10 0.02 0.02
ROE -2.94 0.04 0.04
ROIC 5.05 0.02 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 002078.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 002078.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 002078.SZ is permitted for members.